Maine Quantifies Its Medical Cannabis Testing Gap as a New Patient Advisory Sharpens the Risk
A state audit found 42% of sampled medical cannabis would have failed Maine’s adult-use contamination rules, and a fresh patient advisory shows the exposure is current for patients, caregivers, and lawmakers.
Maine regulators have now attached a number to a dispute that had circulated for years in testimony, complaints, and trade arguments. In a state report based on audit testing of 120 medical cannabis samples, 50 samples, or 42%, contained at least one contaminant at a level that...
Read article